Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Autoimmune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06113900
What this trial is testing

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Who this might be right for
Lupus Nephritis
Ain Shams University 50
Early research (Phase 1)Study completedNCT00705367
What this trial is testing

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 13
Not applicableWithdrawnNCT04369495
What this trial is testing

BAFF Levels and Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Universidad de Antioquia
Not applicableNot Yet RecruitingNCT07183007
What this trial is testing

Development of a Dietary Intervention Model Based on Genetic Data as an Implementation of a Healthy Lifestyle in the Management of Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus
Universitas Indonesia 100
Large-scale testing (Phase 3)UnknownNCT04275193
What this trial is testing

The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Shanghai University of Traditional Chinese Medicine 118
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Not applicableStudy completedNCT03698071
What this trial is testing

Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

Who this might be right for
ANCA Associated Vasculitis
University Hospital, Bordeaux 48
Early research (Phase 1)Study completedNCT01716312
What this trial is testing

Omalizumab for Lupus

Who this might be right for
Systemic Lupus ErthematosusSjogren's Syndrome
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 17
Not applicableUnknownNCT04046172
What this trial is testing

Treatment of Periodontal Disease in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusPeriodontitis
University College, London 200
Very early researchUnknownNCT05085444
What this trial is testing

CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma

Who this might be right for
SclerodermaAutoimmune Diseases
Zhejiang University 9
Early research (Phase 1)Study completedNCT05984251
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants

Who this might be right for
VasculitisSystemic Lupus Erythematosus (SLE)
Amgen 48
Not applicableLooking for participantsNCT06804057
What this trial is testing

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

Who this might be right for
Systemic Lupus Erythematosus
CorEvitas 1,000
Early research (Phase 1)Not Yet RecruitingNCT07676266
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more
The Affiliated Hospital of Qingdao University 18
Not applicableStudy completedNCT06936007
What this trial is testing

Hematological Manifestations in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Patan Academy of Health Sciences 99
Post-approval studies (Phase 4)Active Not RecruitingNCT05879419
What this trial is testing

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondylitis, AnkylosingSpondyloarthritis+8 more
University of Sao Paulo General Hospital 2,005
Not applicableStudy completedNCT01156428
What this trial is testing

Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease

Who this might be right for
ProteinuriaKidney InjuryChronic Kidney Disease
The Rogosin Institute 119
Testing effectiveness (Phase 2)Study completedNCT02554019
What this trial is testing

Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Biotest 36
Testing effectiveness (Phase 2)Ended earlyNCT03712345
What this trial is testing

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA

Who this might be right for
Granulomatosis With Polyangiitis (GPA)Microscopic Polyangiitis (MPA)
InflaRx GmbH 20
Not applicableStudy completedNCT04527172
What this trial is testing

Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus

Who this might be right for
Peripheral NeuropathySystem; Lupus Erythematosus
Assiut University 55
Large-scale testing (Phase 3)UnknownNCT04892212
What this trial is testing

Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis

Who this might be right for
Lupus NephritisImmunosuppressionEffect of Drug
Peking Union Medical College Hospital 20
Next Page